1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE
1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE Basic information
- Product Name:
- 1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE
- Synonyms:
-
- 1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE
- 1-(2-Deoxy-b-D-ribofuranosyl)-5-nitroindole
- 5-Nitroindole 2'-deoxyribonucleoside
- 1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-5-nitro-1H-indole
- 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole
- 2'-DEOXY-NITRO INDOLE NUCLEOSIDE
- 1-(b-D-2-Deoxyribofuranosyl)-5-nitroindole
- 5-NIdR
- CAS:
- 191421-10-0
- MF:
- C13H14N2O5
- MW:
- 278.26
- Mol File:
- 191421-10-0.mol
More
Less
1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE Chemical Properties
- Boiling point:
- 572.5±50.0 °C(Predicted)
- Density
- 1.60±0.1 g/cm3(Predicted)
- storage temp.
- -10 to -25°C
- solubility
- DMSO: 2mg/mL, clear
- form
- Solid
- pka
- 14.01±0.60(Predicted)
- color
- Light yellow to yellow
More
Less
1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE Usage And Synthesis
Uses
5-NIdR (1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole), an artificial nucleoside, exhibits the ability to inhibit the replication of DNA lesions generated by Temozolomide (HY-17364). 5-NIdR induces cancer cells apoptosis and arrests cell cycle at G0 phase. 5-NIdR enhances Temozolomide anti-tumor efficacy in murine glioblastoma model[1].
in vivo
5-NIdR (100 mg/kg; ip; for 5 consecutive days), together with Temozolomide (40 mg/kg), results complete tumor regression in a murine xenograft model of glioblastoma. Temozolomide alone only delayed tumor growth[1].
References
[1] Choi JS, et al. Inhibition of Translesion DNA Synthesis as a Novel Therapeutic Strategy to Treat Brain Cancer. Cancer Res. 2018 Feb 15;78(4):1083-1096. DOI:10.1158/0008-5472.CAN-17-2464
1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLESupplier
Bide Pharmatech Ltd.
- Tel
- 400-164-7117 13681763483
- product02@bidepharm.com
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com
Shenzhen Regent Biochemical Technology Co., Ltd.
- Tel
- 0755-85201366 18938635012
- sales@regentsciences.com
Zhengzhou Granlen Sciences, ltd.
- Tel
- 0371-85513397 +86-18610099868
- info@granlen.com
NewCan Biotech Limited
- Tel
- +86-0571-86912261 +8613735419629
- sales@newcanbio.com